Pfizer $11 Bil. Premium For Pharmacia Calibrated To Merger Savings
This article was originally published in The Tan Sheet
Executive Summary
Pfizer's $11 bil. premium above Pharmacia's recent stock market valuation is a figure calculated from the estimated operating savings in the companies' proposed stock-for-stock transaction